Not applicableLooking for participantsNCT06546267What this trial is testingAdvanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)Who this might be right forProstate Cancer IRCCS San Raffaele 2,500
Testing effectiveness (Phase 2)Ended earlyNCT03050554What this trial is testingSBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)Who this might be right forEarly Stage Non-Small Cell Lung Cancer Andrew Sharabi 2
Testing effectiveness (Phase 2)UnknownNCT02461836What this trial is testingStudy of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1)Who this might be right forPancreatic Cancer Second Affiliated Hospital, Zhejiang University, School of Medicine 513
Testing effectiveness (Phase 2)Study completedNCT03767582What this trial is testingTrial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.Who this might be right forLocally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22
Not applicableStudy completedNCT02516969What this trial is testingSurgery With or Without Adjuvant Stereotactic Body RadiotherapyWho this might be right forHead and Neck Cancer David A. Clump, MD, PhD 7
Testing effectiveness (Phase 2)Study completedNCT01595321What this trial is testingPancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the PancreasWho this might be right forPancreatic Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Not applicableNot Yet RecruitingNCT05411809What this trial is testingThe ctDNA for Evaluating Whether to Use Adjuvant Therapy After SBRT in Patients With Early Lung CancerWho this might be right forStereotactic Body Radiation Therapy Peking University Third Hospital 180
Testing effectiveness (Phase 2)Study completedNCT02057107What this trial is testingSBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHNWho this might be right forPreviously-IrradiatedSquamous Cell Carcinoma of the Head and Neck Cancer Heath Skinner 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03141359What this trial is testingUse of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLCWho this might be right forLung Cancer Stage IILung Cancer Stage IIINon Small Cell Lung Cancer Wake Forest University Health Sciences 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT03875573What this trial is testingNeo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:Who this might be right forLuminal B Jules Bordet Institute 147
Not applicableLooking for participantsNCT04996914What this trial is testingAdjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Non-resectable RWTH Aachen University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04915508What this trial is testingExtremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical ProstatectomyWho this might be right forProstate AdenocarcinomaStage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIIC Prostate Cancer AJCC v8+3 more Jonsson Comprehensive Cancer Center 165
Testing effectiveness (Phase 2)Study completedNCT02723331What this trial is testingPerioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular CorrelatesWho this might be right forPancreatic CancerPancreatic AdenocarcinomaPancreas Ductal Adenocarcinoma Academic Thoracic Oncology Medical Investigators Consortium 48
Not applicableUnknownNCT02446366What this trial is testingHypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by SurgeryWho this might be right forStage II Prostate AdenocarcinomaStage IIB Prostate CancerStage III Prostate Adenocarcinoma University of Southern California 24
Very early researchWithdrawnNCT03574220What this trial is testingPembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Case Comprehensive Cancer Center
Not applicableStudy completedNCT06007118What this trial is testingAdjuvant Partial-breast Irradiation Using Stereotactic Body Radiation TherapyWho this might be right forEarly-stage Breast Cancer Masaryk Memorial Cancer Institute 85
Not applicableNot Yet RecruitingNCT05602974What this trial is testingAdjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III StudyWho this might be right forHepatocellular CarcinomaNarrow MarginAdjuvant Stereotactic Body Radiotherapy+1 more Second Affiliated Hospital, Zhejiang University, School of Medicine 140
Early research (Phase 1)Active Not RecruitingNCT02685332What this trial is testingPhase I Dose Escalation of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation Early Stage Breast CAWho this might be right forEarly Stage Breast Cancer University of Texas Southwestern Medical Center 30
Not applicableLooking for participantsNCT07077239What this trial is testingProstate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing ToxicityWho this might be right forProstate Cancer (CRPC) Jonsson Comprehensive Cancer Center 200
Not applicableWithdrawnNCT02307474What this trial is testingA Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell CancerWho this might be right forClear Cell Renal Cell CarcinomaRenal Cell Carcinoma Case Comprehensive Cancer Center